Document Type : Review Article

Authors

1 Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Comparative Anatomy, Experimental Anatomopathology and Surgery, Faculty of Health Sciences, University des Montagnes, Cameroon

3 1.Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 2. Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Abortion Research Center, Reproductive Sciences Institute, Shahid Sadoughi University of medical sciences, Yazd, Iran

5 LOMO University of Research, Kinshasa, DR Congo

10.22034/hbb.2022.326069.1020

Abstract

Coronavirus is a non-segmented virus related to Coronaviridae family with an envelope and RNA that has a huge positive-sense single-stranded genome. The causative agent of COVID-19 – the severe acute respiratory coronavirus syndrome-2 (SARS-CoV-2) first appeared in China late 2019. The role of these viruses in pneumonia has greatly improved through molecular techniques. The virus structural proteins, viral replication factors, viral endocytosis process and enzymes are the key targets for designing drugs against COVID-19. Furthermore, the main signaling factors may also be used to treat infection with novel antiproliferative drugs. This review considers the main molecular and cellular targets as well as peptide-based and pharmaceutical treatments for COVID-19 aiming for a better design of drugs against viruses with good insights on key factors involved in the infection that may be the target for future research.

Keywords

Main Subjects